Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: ECT Pulse Amplitude and Medial Temporal Lobe Engagement [Phase 4]
Phase 4 trial update evaluating ECT pulse amplitude and medial temporal lobe engagement in major depressive disorder; study completed with r…
-
FDA approval · 2023-07-18FDA Approved: VILAZODONE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental ANDA from Alembic Pharmaceuticals Limited for vilazodone hydrochloride, granting approval of a generic version o…
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder [Phase 3]
A Phase 3 trial comparing sertraline to escitalopram in South Asian participants with moderate to severe major depressive disorder has compl…
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Treatment for Migraine and Mood (Team-M) [Phase 2]
A Phase 2 clinical trial update for a treatment targeting migraine and mood disorders has completed and posted results.
-
FDA approval · 2023-07-17FDA Approved: ARIPIPRAZOLE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for aripiprazole from Ascend Laboratories, allowing a generic version to be marketed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: A Study of HS-10353 in Adult Participants With Major Depressive Disorder [Phase 2]
Phase 2 clinical trial update for HS-10353 in adults with Major Depressive Disorder.
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: Zelquistinel in the Treatment of Adults With Major Depressive Disorder [Phase 1, Phase 2]
Clinical trial update reporting Phase 1/2 results for Zelquistinel in adults with Major Depressive Disorder; the study is completed with res…
-
FDA approval · 2023-07-07FDA Approved: VILAZODONE HYDROCHLORIDE — Original Application (Northstar Rx LLC)
FDA approved the original application for Vilazodone hydrochloride from Northstar Rx LLC, enabling a generic version of the antidepressant i…
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: Effectiveness of Cariprazine Monotherapy for Treatment of Major Depressive Disorder [Phase 4]
Phase 4 clinical trial evaluating cariprazine monotherapy for major depressive disorder is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2023-07-05Clinical Trial Update: Substance Misuse To Psychiatric Disorders for Cannabis [Phase 2, Phase 3]
Phase 2/3 clinical trial update on a substance misuse to psychiatric disorders program focusing on cannabis use disorder with depressive/anx…
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: A Trauma-Informed Intervention for Positive Youth Development and Teacher Wellness in Rural Montana [NA]
Completed clinical trial examining a trauma-informed intervention for positive youth development and teacher wellness in rural Montana; resu…
-
FDA approval · 2023-06-28FDA Approved: MIRTAZAPINE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Mirtazapine by Prasco Laboratories, enabling a generic version of the antidepressant to be marke…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor (SPEAC) for Adults With Emotional Distress (Phase 1) [NA]
Phase 1 clinical trial update evaluating a PST-trained, voice-enabled AI counselor (SPEAC) for adults with emotional distress, including dep…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: The Feasibility of Engage Therapy With Video Support for Homebound Older Adults [NA]
A completed clinical trial evaluating Engage Therapy with video support for homebound older adults with depression; results posted in 2023.
-
FDA approval · 2023-06-27FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Micro Labs Limited)
FDA approved the original abbreviated new drug application for doxepin hydrochloride from Micro Labs Limited. Doxepin hydrochloride is used …
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression [Phase 2]
A Phase 2 study evaluating the efficacy of JNJ-67953964 for major depressive disorder has completed, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD) [Phase 3]
Phase 3 trial evaluating SAGE-217 for severe postpartum depression has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Tolerability, Safety and Efficacy of Vortioxetine [Phase 4]
Phase 4 trial update assessing tolerability, safety, and efficacy of vortioxetine for depression.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Examining Changes in Microbiota Over the Course of PTSD Treatment [NA]
A completed clinical trial examining changes in gut microbiota during treatment for PTSD and depression, with results posted.
-
FDA approval · 2023-06-15FDA Approved: ARIPIPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for aripiprazole from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy [Phase 4]
Phase 4 trial update evaluating adjunctive mixed salts amphetamine for adults with major depressive disorder not fully responding to antidep…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: PracticeGround: Transforming Training and Delivery of Mental Health EBPs [NA]
A completed clinical trial evaluating PracticeGround training and delivery of mental health evidence-based practices; results were posted in…
-
FDA approval · 2023-06-12FDA Approved: ARIPIPRAZOLE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for ARIPIPRAZOLE submitted by Unichem Pharmaceuticals (USA), Inc., enabling the generic product to b…
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Leucine for Depression Study (L-DEP) [EARLY_Phase 1]
Early-phase clinical trial update for Leucine in depression; study terminated with results posted.
-
FDA approval · 2023-06-07FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride by Macleods Pharmaceuticals Limited.